No new guidance, but here's some advice: FDA draws a line in the sand for Covid-19 vaccine developers
Less than a day after reports emerged that the White House cited industry opposition in a move to block stricter Covid-19 vaccine guidelines, the FDA is spelling out exactly what regulators have been communicating to developers looking for an emergency use authorization.
In doing so, the regulators are officially drawing a line in the sand amid an increasingly chaotic campaign to bring a vaccine to market at record speed.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.